The Niche

Al Gore, Shinya Yamanka, Genentech’s VCs, and induced pluripotency

iZumi Biotech has just announced a dream team, but they aren’t saying much about what exact game they’ll be playing with induced pluripotent stem cells. Here is the article in USA Today , announcing a deal with Kyoto University’s Shinya Yamanaka, who figured out how to transform specialized cells to an embryonic-like state. iZumi already has an agreement with the Gladstone Institute in San Francisco, where Yamanaka has a joint appointment. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE